Implementation of GLP-1 based therapy of type 2 diabetes mellitus using DPP-IV inhibitors.

Medicin og biovidenskab

• Glucagon-Like Peptide 1 100%
• Type 2 Diabetes Mellitus 64%
• Hormones 60%
• Psychological Inhibition 55%
• Gastrointestinal Motility 41%
• Insulin Secretion 33%
• Eating 25%
• Insulin 23%
• Dipeptidyl Peptidase 4 22%
• Incretins 22%
• Peptides 21%
• Glucose 21%
• Peptide Hormones 20%
• Enzyme Inhibitors 19%
• Sensory Receptor Cells 18%
• Intestinal Mucosa 18%
• Appetite 17%
• Glucagon 17%
• Islets of Langerhans 17%
• Small Intestine 15%
• Meals 15%
• Nutrients 14%
• Therapeutics 13%
• Fasting 13%
• Central Nervous System 12%
• Stem Cells 12%
• Apoptosis 10%
• Gene Expression 10%
• Enzymes 9%

Kemiske forbindelser

• Hormone 85%
• Insulin Derivative 69%
• Inhibition of Apoptosis 31%
• Glucose 25%
• Glucagon 23%
• Peptide Hormone 22%
• Peptide 19%
• Nutrient 18%
• Biosynthesis 14%
• Pharmacological Metabolism 13%
• Food 12%